Fundz

Fundz Deep Dive

Everything you need to win Benjamin Chien — in one platform.

Who to reach, what to say, and why now on Benjamin Chien — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Benjamin Chien — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Qps Adds Derek Grimes To Global Leadership Team for Clinical Research Alignment

PRIVATEJun 21, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

QPS HOLDINGS

Benjamin Chien
NewarkBiotechnologyHealth CarePharmaceutical

Description

QPS is pleased to announce the addition of Mr. Derek Grimes to the QPS Global Leadership Team, aiming to enhance collaboration between different business units and provide comprehensive tailored clinical development programs, focusing on the future of Biologics and Advanced Therapy programs as well as the rising demand for accelerated clinical studies.

Company Information

Company

QPS HOLDINGS

Location

Newark, Delaware, United States

About

QPS is a leading global full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. It has grown from a small bioanalysis shop into a full-service CRO with 1,100+ employees in the US, Europe, and Asia, offering expanded pharmaceutical contract R&D services with special expertise in various areas such as pharmacology, DMPK, toxicology, bioanalysis, translational medicine, clinical trials, and clinical research services.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for QPS HOLDINGS's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.